论文部分内容阅读
目的:分析奥美拉唑、莫沙必利联合铝碳酸镁治疗反流性食道炎的临床效果。方法:选取2012年1月~2015年12月我院反流性食道炎患者130例分组研究,将其分为实验组和对照组,试验组在常规奥美拉唑联合莫沙必利治疗基础上加用铝碳酸镁,对照组采用常规奥美拉唑联合莫沙必利治疗,观察两组患者的治疗效果。结果:试验组治疗总有效率明显高于对照组,P<(0.05),试验组与对照组不良反应比较无统计学意义,P>(0.05)。结论:奥美拉唑、莫沙比利联合铝碳酸镁咀嚼片治疗反流性食道炎疗效显著高于奥美拉唑联合莫沙必利,且未增加不良反应,具有临床价值。
Objective: To analyze the clinical effects of omeprazole and mosapride in combination with magnesium aluminum carbonate in the treatment of reflux esophagitis. Methods: 130 patients with reflux esophagitis in our hospital from January 2012 to December 2015 were divided into experimental group and control group. The experimental group was treated with conventional omeprazole combined with mosapride Addition of aluminum magnesium carbonate, the control group with conventional omeprazole combined with mosapride treatment, the treatment of two groups were observed. Results: The total effective rate of the experimental group was significantly higher than that of the control group (P <0.05). There was no significant difference between the experimental group and the control group (P> 0.05). Conclusion: The omeprazole and mosapride combined with aluminum magnesium carbonate chewable tablets in the treatment of reflux esophagitis was significantly higher than omeprazole combined with mosapride, and did not increase adverse reactions, with clinical value.